A webcast of Baxter's first quarter conference call for investors can be accessed live from a link on the company's website at http://www.baxter.com beginning at 7:30 a.m. CDT on April 17, 2008. Please visit Baxter's website for more information regarding this and future investor events and webcasts, including investor presentations, and the company's Annual Meeting of Shareholders to be held in Chicago on May 6, 2008.
Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with the treatment of complex medical conditions, including hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma and other conditions. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.
This release includes forward-looking statements concerning the
company's financial results. The statements are based on assumptions about
many important factors, including the following, which could cause actual
results to differ materially from those in the forward-looking statements:
demand for and market acceptance risks for new and existing products, such
as ADVATE, and other technologies; future actions of regulatory bodies and
other governmental authorities, including the FDA and foreign counterparts,
that could delay, limit or suspend product development, manufacturing or
sales or result in sanctions; product quality or patient safety concerns
leading to product recalls, withdrawals, launch delays, litigation, or
declining sales; product development risks; inventory reductions or
fluctuations in buying patterns by wholesalers or distributors; the impact
of geographic and product mix on the company's sales; the impact of
competitive products and pricing, including generic competition, drug
reimportation and di
|SOURCE Baxter International Inc.|
Copyright©2008 PR Newswire.
All rights reserved